Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.
Daniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.
Survey responses revealed the rates and times at which patients switched from oral to biologic therapies.
Findings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.
Expert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.
Jeffrey Yager, MD, discusses the new SY Aesthetics campus that will integrate traditional and Chinese healing.
In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.
In this study, researchers treated 37 basal cell carcinoma (BCC) lesions from 30 patients, with follow-ups at 5 time points after baseline examination.
Health care professionals are recognizing the growing need for advanced technology in modern medical practice.
Peter Lio, MD, reflects on current unmet needs in atopic dermatitis and suggests directions for future research and development.
López-Ferrer discussed how to achieve well-being for patients with psoriasis and Koscielny discussed the unique topics of the Skin Academy.
Experts discuss the treatment landscape of generalized pustular psoriasis as well as review difficult cases of GPP.
Jerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.
As SDPA summer sessions have concluded, Arash Mostaghimi, MD, MPA, MPH, delves into what lies ahead in the dermatology industry—including the importance of collaboration between physicians and PAs.
The poster, which shares results form consensus research on using LODM for hair loss, was awarded 4th place at the 2024 AAD Annual Meeting.
By integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.
The investigator in the clinical development program for deuruxolitinib shared data, patient populations to consider, and more in a recent interview.
A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Continuing the discussion on the case of a 17-year-old patient with moderate acne, Heather Woolery-Lloyd, MD, FAAD, provides an overview of the utilization of clascoterone cream, highlighting the application process and its unique mechanism of action.
FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Drs Joshua Zeichner, MD, and Mona Gohara, MD, provide take-home messages to providers treating patients with acne.
CDC advises not to delay shingles vaccination.
The approval of Galderma’s Restylane Eyelight was one of Martin’s top highlights of 2023.
More than 90% of respondents to a recent survey expressed concern about acne’s effect on their adolescent’s mental health and social life.
A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
J.D. Norcross, director of information technology at VitalSkin Dermatology, discusses some myths and best practices with digital passwords you should know to help keep your practice information safer.